01—History
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $593.0M
4 older moves run past ±150% (largest +730163.1%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is Moderna, Inc.'s current financing cash flow?
Moderna, Inc. (MRNA) annual financing cash flow for 2025 was $593.0M, a 958.93% increase from 2024. Moderna, Inc. financing cash flow for the quarter ending March 31, 2026 was $17.0M.
What was Moderna, Inc.'s financing cash flow in 2024?
Moderna, Inc. annual financing cash flow for 2024 was $56.0M, a 104.07% increase from 2023.
What was Moderna, Inc.'s financing cash flow in 2023?
Moderna, Inc. annual financing cash flow for 2023 was $-1.38B, a 60.06% increase from 2022.
What is Moderna, Inc.'s 5-year financing cash flow CAGR?
Moderna, Inc. financing cash flow grew at a compound annual growth rate (CAGR) of 21.84% from FY2020 to FY2025, going from $2.03B to $593.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)